Hepatocytes prepared from mice suffering from NASH express enhanced levels of NLRP3 inflammasome components and have the capacity to release IL-1β in response to palmitate, a saturated fatty acid, in combination with LPS [176]. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.